These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17634114)

  • 1. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.
    Pluta K; Diehl W; Zhang XY; Kutner R; Bialkowska A; Reiser J
    BMC Biotechnol; 2007 Jul; 7():41. PubMed ID: 17634114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
    J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter cross-talk affects the inducible expression of intronic shRNAs from the tetracycline response element.
    Park SK; Hwang BJ; Kee Y
    Genes Genomics; 2019 Apr; 41(4):483-490. PubMed ID: 30656518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines.
    Henriksen JR; Løkke C; Hammerø M; Geerts D; Versteeg R; Flaegstad T; Einvik C
    Nucleic Acids Res; 2007; 35(9):e67. PubMed ID: 17426119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
    Fish RJ; Kruithof EK
    BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.
    Ogueta SB; Yao F; Marasco WA
    Mol Med; 2001 Aug; 7(8):569-79. PubMed ID: 11591893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A versatile tool for conditional gene expression and knockdown.
    Szulc J; Wiznerowicz M; Sauvain MO; Trono D; Aebischer P
    Nat Methods; 2006 Feb; 3(2):109-16. PubMed ID: 16432520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of mammalian genes by tetracycline-inducible shRNA expression.
    Kappel S; Matthess Y; Kaufmann M; Strebhardt K
    Nat Protoc; 2007; 2(12):3257-69. PubMed ID: 18079726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.
    Aagaard L; Amarzguioui M; Sun G; Santos LC; Ehsani A; Prydz H; Rossi JJ
    Mol Ther; 2007 May; 15(5):938-45. PubMed ID: 17311008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline-dependent inducible and reversible RNA interference mediated by a single lentivirus vector.
    Matsushita N; Matsushita S; Hirakawa S; Higashiyama S
    Biosci Biotechnol Biochem; 2013; 77(4):776-81. PubMed ID: 23563548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.
    Schmeisser F; Donohue M; Weir JP
    Hum Gene Ther; 2002 Dec; 13(18):2113-24. PubMed ID: 12542843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vector-based RNA interference to study gene function in cancer.
    Stovall DB; Wan M; Zhang Q; Dubey P; Sui G
    J Vis Exp; 2012 Jun; (64):e4129. PubMed ID: 22710444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pHUSH: a single vector system for conditional gene expression.
    Gray DC; Hoeflich KP; Peng L; Gu Z; Gogineni A; Murray LJ; Eby M; Kljavin N; Seshagiri S; Cole MJ; Davis DP
    BMC Biotechnol; 2007 Sep; 7():61. PubMed ID: 17897455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1.
    Matthess Y; Kappel S; Spänkuch B; Zimmer B; Kaufmann M; Strebhardt K
    Oncogene; 2005 Apr; 24(18):2973-80. PubMed ID: 15735719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.
    Frank SB; Schulz VV; Miranti CK
    BMC Biotechnol; 2017 Feb; 17(1):24. PubMed ID: 28245848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional gene expression and knockdown using lentivirus vectors encoding shRNA.
    Szulc J; Aebischer P
    Methods Mol Biol; 2008; 434():291-309. PubMed ID: 18470652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system.
    Kuninger D; Stauffer D; Eftekhari S; Wilson E; Thayer M; Rotwein P
    Hum Gene Ther; 2004 Dec; 15(12):1287-92. PubMed ID: 15684704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-vector inducible lentiviral RNAi system for oncology target validation.
    Wiederschain D; Wee S; Chen L; Loo A; Yang G; Huang A; Chen Y; Caponigro G; Yao YM; Lengauer C; Sellers WR; Benson JD
    Cell Cycle; 2009 Feb; 8(3):498-504. PubMed ID: 19177017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.